Literature DB >> 24908598

In vitro evaluation of the enzymatic activity profile of non-albicans Candida species isolated from patients with oral candidiasis with or without diabetes.

Paula Volpato Sanitá1, Chaiene Evelin Zago2, Ewerton Garcia de Oliveira Mima3, Ana Cláudia Pavarina4, Janaina Habib Jorge3, Ana Lúcia Machado5, Carlos Eduardo Vergani6.   

Abstract

OBJECTIVE: To evaluate the expression of phospholipase (PL) and secreted aspartyl proteinase (SAP) by Candida glabrata and C tropicalis obtained from the denture biofilms of healthy participants (16 isolates), patients with oral candidiasis with diabetes (10 isolates), and patients with oral candidiasis without diabetes (25 isolates). STUDY
DESIGN: After incubation, the supernatants and pellets of the isolates were used for the enzymatic assays and quantification of colony-forming units (CFU), respectively. Colorimetric tests were used with phosphatidylcholine as a substrate for PL and azocasein as a substrate for SAP, and the absorbances of the samples were measured. Enzymatic rates were calculated, and values were normalized by CFU. Results were analyzed with factorial analyses of variance (α = .05).
RESULTS: C tropicalis and C glabrata were proteolytic and phospholipolytic. The clinical sources of isolates had no significant effect on the enzymatic activities (P > .05). C tropicalis had significantly higher enzymatic activity for both PL and SAP (P < .001) than did C glabrata.
CONCLUSIONS: C tropicalis isolates produced significantly higher amounts of both enzymes than did the C glabrata isolates.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24908598     DOI: 10.1016/j.oooo.2014.03.020

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  8 in total

1.  Virulence factors of fluconazole-susceptible and fluconazole-resistant Candida albicans after antimicrobial photodynamic therapy.

Authors:  Fernanda Alves; Ewerton Garcia de Oliveira Mima; Renata Caroline Polato Passador; Vanderlei Salvador Bagnato; Janaína Habib Jorge; Ana Cláudia Pavarina
Journal:  Lasers Med Sci       Date:  2017-03-09       Impact factor: 3.161

2.  Candida albicans Multilocus Sequence Typing Clade I Contributes to the Clinical Phenotype of Vulvovaginal Candidiasis Patients.

Authors:  Yuxia Zhu; Chao Fang; Yu Shi; Yingying Shan; Xiaoping Liu; Yiheng Liang; Liting Huang; Xinyang Liu; Chunfeng Liu; Yin Zhao; Shangrong Fan; Xiaowei Zhang
Journal:  Front Med (Lausanne)       Date:  2022-04-01

3.  Dynamics of biofilm formation and the interaction between Candida albicans and methicillin-susceptible (MSSA) and -resistant Staphylococcus aureus (MRSA).

Authors:  Chaiene Evelin Zago; Sónia Silva; Paula Volpato Sanitá; Paula Aboud Barbugli; Carla Maria Improta Dias; Virgínia Barreto Lordello; Carlos Eduardo Vergani
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

Review 4.  An Update on Candida tropicalis Based on Basic and Clinical Approaches.

Authors:  Diana L Zuza-Alves; Walicyranison P Silva-Rocha; Guilherme M Chaves
Journal:  Front Microbiol       Date:  2017-10-13       Impact factor: 5.640

5.  A Chitin-binding Protein Purified from Moringa oleifera Seeds Presents Anticandidal Activity by Increasing Cell Membrane Permeability and Reactive Oxygen Species Production.

Authors:  João X S Neto; Mirella L Pereira; Jose T A Oliveira; Lady C B Rocha-Bezerra; Tiago D P Lopes; Helen P S Costa; Daniele O B Sousa; Bruno A M Rocha; Thalles B Grangeiro; José E C Freire; Ana Cristina O Monteiro-Moreira; Marina D P Lobo; Raimunda S N Brilhante; Ilka M Vasconcelos
Journal:  Front Microbiol       Date:  2017-06-06       Impact factor: 5.640

6.  Breakthrough Bloodstream Infections Caused by Echinocandin-Resistant Candida tropicalis: An Emerging Threat to Immunocompromised Patients with Hematological Malignancies.

Authors:  Maroun M Sfeir; Cristina Jiménez-Ortigosa; Maria N Gamaletsou; Audrey N Schuetz; Rosemary Soave; Koen Van Besien; Catherine B Small; David S Perlin; Thomas J Walsh
Journal:  J Fungi (Basel)       Date:  2020-01-31

7.  In vitro antifungal activity of different components of Centratherum anthelminticum and Ocimum sanctum seed oils and their synergism against oral pathogenic fungi.

Authors:  Aparna H Gopalkrishna; Seshagiri M; Sunil Muddaiah; Shashidara R
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2016-06-15

8.  The Candida species that are important for the development of atrophic glossitis in xerostomia patients.

Authors:  Sachika Nakamura; Mariko R Okamoto; Ken Yamamoto; Akihisa Tsurumoto; Yoko Yoshino; Hiroshi Iwabuchi; Ichiro Saito; Nobuko Maeda; Yoichi Nakagawa
Journal:  BMC Oral Health       Date:  2017-12-16       Impact factor: 2.757

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.